XML 158 R139.htm IDEA: XBRL DOCUMENT v3.25.0.1
SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT- Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Net Cash Provided by (Used in) Operating Activities [Abstract]      
Net income (loss) attributable to RenaissanceRe $ 1,870,360 $ 2,561,132 $ (1,061,203)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities      
Net realized and unrealized (gains) losses on investments (29,439) (482,794) 1,635,192
Other (371,707) (579,280) (259,168)
Net cash provided by (used in) operating activities 4,164,822 1,911,634 1,603,683
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Proceeds from sales and maturities of fixed maturity investments trading 23,515,450 21,796,577 22,086,168
Purchases of fixed maturity investments trading (26,296,842) (24,771,411) (24,923,131)
Return of investments in other ventures 41,349 5,554 2,248
Net purchase of Validus 0 (2,433,746) 0
Net cash provided by (used in) investing activities (3,060,856) (3,822,636) (3,016,176)
Cash flows provided by (used in) financing activities      
Dividends paid – RenaissanceRe common shares (80,849) (75,112) (64,675)
Dividends paid – preference shares (35,375) (35,375) (35,396)
RenaissanceRe common share repurchases (666,921) 0 (166,664)
RenaissanceRe common share issuance, net of expenses 0 1,351,608 0
Issuance of debt, net of expenses 0 740,581 0
Taxes paid on withholding shares (23,580) (20,518) (10,911)
Net cash provided by (used in) financing activities (1,287,515) 2,588,639 725,342
Effect of exchange rate changes on foreign currency cash (17,365) 5,542 22,471
Net increase (decrease) in cash and cash equivalents (200,914) 683,179 (664,680)
Cash and cash equivalents, beginning of year 1,877,518 1,194,339 1,859,019
Cash and cash equivalents, end of year 1,676,604 1,877,518 1,194,339
Parent Company      
Net Cash Provided by (Used in) Operating Activities [Abstract]      
Net income (loss) attributable to RenaissanceRe 1,870,360 2,561,131 (1,061,204)
Less: equity in net income (loss) of subsidiaries (2,017,805) (2,708,061) 988,610
Loss before equity in net income of subsidiaries (147,445) (146,930) (72,594)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities      
Net realized and unrealized (gains) losses on investments 334 67,868 2,051
Other 142,051 72,691 36,601
Net cash provided by (used in) operating activities (5,060) (6,371) (33,942)
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Proceeds from sales and maturities of fixed maturity investments trading 309,490 1,613,740 198,341
Purchases of fixed maturity investments trading (387,276) (1,505,160) (375,804)
Net sales (purchases) of short term investments 147,296 (211,370) (21,037)
Return of investments in other ventures 1,079,438 1,097,301 1,009,108
Contributions to subsidiaries (247,147) (169,204) (349,336)
Due to (from) subsidiary (115,041) (7,088) (178,470)
Net cash provided by (used in) investing activities 786,760 (1,916,781) 282,802
Cash flows provided by (used in) financing activities      
Dividends paid – RenaissanceRe common shares (80,850) (75,112) (64,675)
Dividends paid – preference shares (35,375) (35,375) (35,396)
RenaissanceRe common share repurchases (666,921) 0 (166,664)
RenaissanceRe common share issuance, net of expenses 0 1,351,608 0
Issuance of debt, net of expenses 0 740,581 0
Taxes paid on withholding shares (23,580) (20,518) (10,911)
Net cash provided by (used in) financing activities (806,726) 1,961,184 (277,646)
Effect of exchange rate changes on foreign currency cash 0 0 0
Net increase (decrease) in cash and cash equivalents (25,026) 38,032 (28,786)
Cash and cash equivalents, beginning of year 45,080 7,048 35,834
Cash and cash equivalents, end of year 20,054 45,080 7,048
Parent Company | Validus Specialty      
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Due to (from) subsidiary 0 (45,467) 0
Parent Company | Validus Holdings, Ltd and Talbot Underwriting Limited      
Net Cash Provided by (Used in) Investing Activities [Abstract]      
Net purchase of Validus $ 0 $ (2,689,533) $ 0